Laboratory Response to 2014 Ebola Virus Outbreak in Mali.

Autor:	Diarra B; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Safronetz D; Laboratory of Virology., Sarro YD; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Kone A; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Sanogo M; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Tounkara S; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Togo AC; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Daou F; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Maiga AI; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Dao S; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Rosenke K; Laboratory of Virology., Falzarano D; Laboratory of Virology., Doumbia S; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Zoon KC; Cytokine Biology Section, Division of Intramural Research., Polis M; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Siddiqui S; Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Sow S; Centre des Operations d'Urgence (Malian Center for Emergency Operations), Centre National d'Appui a la lutte contre la Maladie (Malian Center for Disease Control), Ministry of Health, Bamako, Mali., Schwan TG; Laboratory of Zoonotic Pathogens, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana., Feldmann H; Laboratory of Virology., Diallo S; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali., Koita OA; SEREFO Laboratory, University Clinical Research Center, Faculty of Sciences and Technology, University of Sciences, Techniques and Technologies of Bamako, Mali.
Jazyk:	angličtina
Zdroj:	The Journal of infectious diseases [J Infect Dis] 2016 Oct 15; Vol. 214 (suppl 3), pp. S164-S168.
DOI:	10.1093/infdis/jiw200
Abstrakt:	Aware of the rapid spread of Ebola virus (EBOV) during the current West African epidemic, Mali took several proactive steps to rapidly identify cases within its borders. Under the Mali International Center for Excellence in Research program, a collaboration between the National Institute of Allergy and Infectious Diseases and the Malian Ministry of Higher Education and Scientific Research established a national EBOV diagnostic site at the University of Sciences, Techniques and Technologies of Bamako in the SEREFO Laboratory. Two separate introductions of EBOV occurred in Mali from neighboring Guinea, but both chains of transmission were quickly halted, and Mali was declared "Ebola free" on 18 January 2015 and has remained so since. The SEREFO Laboratory was instrumental in the success of Mali's Ebola response by providing timely and accurate diagnostics. As of today, the SEREFO Laboratory has tested 103 samples from 88 suspected cases, 10 of which were EBOV positive, since the Ebola diagnostics unit started in April 2014. The establishment of Ebola diagnostics in the SEREFO Laboratory, safety precautions, and diagnostics are described. (© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu